SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015957
Filing Date
2020-08-14
Accepted
2020-08-14 17:20:42
Documents
79
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 836740
2 ex31-1.htm EX-31.1 17735
3 ex31-2.htm EX-31.2 17398
4 ex32-1.htm EX-32.1 7124
5 ex32-2.htm EX-32.2 6998
6 image_01.jpg GRAPHIC 6132
  Complete submission text file 0001493152-20-015957.txt   4083741

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE owpc-20200630.xml EX-101.INS 611545
8 XBRL SCHEMA FILE owpc-20200630.xsd EX-101.SCH 57683
9 XBRL CALCULATION FILE owpc-20200630_cal.xml EX-101.CAL 64547
10 XBRL DEFINITION FILE owpc-20200630_def.xml EX-101.DEF 179311
11 XBRL LABEL FILE owpc-20200630_lab.xml EX-101.LAB 346219
12 XBRL PRESENTATION FILE owpc-20200630_pre.xml EX-101.PRE 278151
Mailing Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118
Business Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118 7026050605
One World Pharma, Inc. (Filer) CIK: 0001622244 (see all company filings)

IRS No.: 611744826 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56151 | Film No.: 201106667
SIC: 2834 Pharmaceutical Preparations